Doctor Directory

Below, is a listing of doctors – surgeons, oncologists, radiologists – who have treated fibrolamellar.  In addition, there are others who have not yet come to the attention of FCF.  Contact one of the comprehensive cancer centers in the United States for additional names if your area is not listed here.  Doctors below are listed by region and then alphabetically.

New York City

  • Ghassan Abou-Alfa, M.D., Asst. Professor of Medicine, Gastrointestinal Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
  • Ronald DeMatteo, M.D., Vice Chair, Department of Surgery; Head, Division of General Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
  • Michael P. LaQuaglia, MD, FACS, FRCS, Chief, Pediatric Surgical Service, Joseph H. Burchenal Chair in Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY


  • Linda M. Cardinal, MD, Surgeon, Kaiser Permanente, Tyson’s Corner Medical Center, McLean, VA
  • Stephen J. Cohen, M.D., Chief, Gastrointestinal Medical Oncology
    Medical Director, Medical Oncology, Fox Chase Cancer Center Partners C0-Leader,
    Gastrointestinal Cancer Service Line, Fox  Chase Cancer Center, Philadelphia, PA
  • Elliot K. Fishman, M.D., Professor of Oncology, Radiology and Radiological Science, Johns Hopkins Hospital; Director, Diagnostic Imaging and Body CT, Johns Hopkins University School of Medicine, Baltimore, MD
  • Ephriam Fuchs, M.D., Associate Professor of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
  • Howard Katzenstein, M.D., Professor of Pediatrics, Scott and Tracie Hamilton Chair in Cancer Survivorship,Medical Director, Pediatric Hematology Oncology, Vanderbilt University School of Medicine, Nashville, TN
  • John C. Rhee, MD, medical oncologist and hematologist, University of Pittsburgh Cancer Center (Hillman Cancer Center), Pittsburgh, PA
  • Perry Shen, M.D., Associate Professor, General Surgery, Comprehensive Cancer Center, Wake Forest Baptist Medical Center, Winston-Salem, NC
  • Jennifer Steel, PhD, Clinical Psychologist, Liver Team at UPMC, University of Pittsburgh Medical Center (UPMC Montefiore), Pittsburgh, PA
  • Melanie B. Thomas, M.D., MS., Medical Oncologist, President, CanLiv – The Hepatobiliary Cancers Foundation, Charleston, SC
  • Allan Tsung, MD, Roberta G. Simmons Asst. Professor of Surgery, University of Pittsburgh School of Medicine, surgical oncologist, UPMC Liver Cancer Center, Pittsburgh, PA
  • William H. Westra, M.D., Professor of Pathology, Oncology, Otolaryngology; Co-Director, Division of Surgical Pathology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
  • Emmanuel Zervos, M.D., surgical oncology, Leo Jenkins Cancer Center, Greenville, NC

New England

  • Charles Fuchs, M.D., M.P.H., Associate Professor, Department of Medicine, Harvard Medical School, Associate Professor of Medicine, Department of Medical Oncology; Director, Gastrointestinal Malignancy Program, Dana-Farber Cancer Institute, Boston, MA
  • Jeff Geschwind, MD, Chair of Yale Diagnostic Radiology, Yale School of Medecine; Chief of Diagnostic Radiology at Yale-New Haven Hospital, New Haven, CT
  • Roger Jenkins, MD, Hepatopancreaticobiliary Surgery, Lahey Clinic, Burlington, MA
  • Olga Kozyreva, MD, Oncologist/Hematologist, Dana-Farber Cancer Institute at St. Elizabeth’s Medical Center, Boston, MA
  • Robert J. Mayer, MD, Faculty Vice President for Academic Affairs,  Stephen B. Kay Family Professor of Medicine, Harvard Medical SchoolDana-Farber Cancer Institute, Boston, MA
  • Andrew Zhu, M.D., Ph.D., Assistant Professor, Department of Medicine, Harvard Medical School; Asst. Physician, Hematology/Oncology and Director of Liver Cancer Research at Massachusetts General Hospital Cancer Center, Boston, MA


  • Mir Ali, M.D., hematology, oncology and medical oncology, Cleveland Clinic Family Health and Surgery Center, Strongsville, OH
  • Daniel M. Anderson, M.D., Regions Hospital – Cancer Care Center, St. Paul, MN;  University of Minnesota Physicians-Transplant & Medicine Specialties Clinic, Minneapolis, MN
  • David M. Nagorney, M.D., gastroenterologic and general surgery, Mayo Clinic, Rochester, MN
  • Robert Pelley, M.D., solid tumor oncology, Cleveland Clinic, Cleveland, OH


  • William P. Harris, M.D. Acting Instructor, Medical Oncology, Seattle Cancer Center, School of Medicine, Division of Oncology, Seattle, WA
  • Sam H. Whiting, MD. Ph.D., specializes in hepatocellular carcinoma, liver cancer, liver metastasis at Seattle Cancer Care Alliance, Seattle, WA
  • Raymond S. Yeung, M.D, FACS, surgical oncology multidisciplinary therapy for gastrointestinal malignancies hepato-biliary, pancreas, colorectum, breast cancer, melanoma and endocrine neoplasia scintigraphic mapping, laparoscopic radiofrequency ablation at University of Washington Medical Center, Seattle, WA


  • Michael A. Choti, MD, MBA, Professor and Chairman, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX
  • Cynthia E. Herzog, M.D., Professor, Department of Pediatrics Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
  • Filip Janku, M.D., Ph.D., Associate Member, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center  Houston, TX
  • Ahmed O. Kaseb, M.D., Department of Gastrointestinal Medical Oncology, Assistant Professor and Director, Hepatocellular Carcinoma Program, The University of Texas M.D. Anderson Cancer Center, Houston, TX
  • Yehuda Z. Patt, M.D., Professor of Medicine, Chief of GI Oncology, Research University of New Mexico Cancer Center, Albuquerque, NM
  • Jean-Nicolas Vauthey, M.D., Professor of Surgery and Chief of the Liver Service, Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.


  • Ronald Busuttll, MD, PhD, Transplant Surgeon, Phleger Liver Institute, UCLA Medical Center, Los Angeles, CA
  • Steven D. Colquhoun, MD, FACS, Surgical Director, Liver Transplantation, Cedars Sinai, Los Angeles, CA
  • Yuman Fong, M.D., Chair, Department of Surgery, Associate Director for International Relations, Professor of Surgery, City of Hope, Duarte, CA
  • James Fuesner, MD, Medical Director, Oncology Program, Division of Hematology/OncologyClinical Scientist, Children’s Hospital Oakland Research Institute (CHORI), Oakland, CA
  • Alan Hemming, MD, MSc, FRCSC, FACS, Chief of Transplantation and Hepatobiliary Surgery, Professor of Surgery, UC San Diego Health, La Jolla, CA
  • Alan P Venook, M.D., Professor of Clinical Medicine, Division of Medical Oncology, University of California, San Francisco, CA



  • Dr. Paul Mainwaring, Oncologist, Mater Private Hospital in Brisbane, Qld, Australia.


  • Dr. Graeme Alexander, Consultant Hepatologist, Cambridge Hepatobiliary Service, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, England
  • Dr. C. Briggs, Consultant Hepatobiliary and Pancreatic Surgeon, Derrriford Hospital, Derriford Road, Crownhill Plymouth, Devon PL6 8DH, England
  • Mr. Paul Gibbs, Senior Lecturer/Honorary Consultant HPB and Lead Transplant Surgeon, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, England
  • Dr. Tim Meyer, Clinical Oncologist, Royal London Free Hospital, Pond Street NW32QG, London, England


  • Professor John Crown, Oncologist, St. Vincent’s Private, Dublin, Ireland
  • Donal Maguire, Consultant General Surgeon, Hepatobilliary, St. Vincent’s Private, Dublin, Ireland


  • Shimon Slavin, M.D., Professor of Medicine, Scientific & Medical Director, The International Center for Cell Therapy & Cancer Immunotherapy (CTCI), Weizman Center, Tel Aviv , ISRAEL